Mary Camargo Email Address
@intarcia.com
Director of Supply Chain Management
Intarcia Therapeutics, Inc., incorporated in June 1995, is a biopharmaceutical company with an approach to acquire, develop and commercialize therapeutic products for the treatment of cancer and infectious diseases. The Company is developing atamestane, its aromatase inhibitor, in combination with toremifene, an approved estrogen receptor blocker, for the treatment of hormone-dependent breast cancer in postmenopausal women. During the year ended December 31, 2004, Intarcia Therapeutics, Inc. was in Phase III clinical development with this combination for the initial or first line treatment of hormone-dependent advanced (metastatic or locally advanced) breast cancer in postmenopausal women. It is developing omega DUROS, a subcutaneous implant designed to deliver its omega interferon, for the treatment of hepatitis C. The Company has completed a Phase II clinical trial of omega interferon.
Supply Chain Professional
Other people working at Intarcia Therapeutics:
How does this work?
Anymail finder is trusted by tens of thousands of companies to provide accurate contact information to their Sales and Business Development teams.
If you're looking to find the email of Mary Camargo at Intarcia Therapeutics then you've come to the right place.
Wondering if it's mary@intarcia.com, mary.camargo@intarcia.com, camargo@intarcia.com, or mcamargo@intarcia.com? We have the answers for you.